XML 24 R4.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements Of Operations - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Operating expenses:      
Research and development, net of grant reimbursement $ 68,032 $ 24,813 $ 3,053
General and administrative 11,988 8,055 3,739
Gain on sale of property and equipment     (346)
Total operating expenses 80,020 32,868 6,446
Operating loss (80,020) (32,868) (6,446)
Interest income 2,777 49 112
Other income, net 997 434  
Net loss $ (76,246) $ (32,385) $ (6,334)
Net loss per share, basic and diluted $ (1.90) $ (0.82) $ (0.24)
Shares used in computing net loss per share, basic and diluted 40,202 39,405 26,105